2000
DOI: 10.1016/s0006-8993(00)02055-2
|View full text |Cite
|
Sign up to set email alerts
|

Positive and negative modulation of the GABAA receptor and outcome after traumatic brain injury in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(28 citation statements)
references
References 50 publications
0
28
0
Order By: Relevance
“…Benzodiazepines, for example, are known to protect the brain from excessive seizure activity while concurrently protecting neurons (Borromei et al, 1997;Sanchez-Izquierdo-Riera et al, 1998). However, giving benzodiazepines (a GABA A receptor agonist) chronically to injured rats will impair their behavioral performance, whereas the post-injury administration of bicuculline (a competitive GABA A receptor antagonist) has been shown to enhance behavioral performance (Schallert et al, 1986;O'Dell et al, 2000). The same can be said about ketamine and other similar drugs which are known to be neuroprotective, but tend to reduce the excitatory tone of brain activity (Barth et al, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…Benzodiazepines, for example, are known to protect the brain from excessive seizure activity while concurrently protecting neurons (Borromei et al, 1997;Sanchez-Izquierdo-Riera et al, 1998). However, giving benzodiazepines (a GABA A receptor agonist) chronically to injured rats will impair their behavioral performance, whereas the post-injury administration of bicuculline (a competitive GABA A receptor antagonist) has been shown to enhance behavioral performance (Schallert et al, 1986;O'Dell et al, 2000). The same can be said about ketamine and other similar drugs which are known to be neuroprotective, but tend to reduce the excitatory tone of brain activity (Barth et al, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…Our results are consistent with a previous observation that GABAergic neocortical neurons are resistant to NMDA receptor-mediated injury (Tecoma and Choi, 1989). Exogenous administration of diazepam, an allosteric GABA potentiator, also has been shown to reduce postischemic and traumatic neuronal death in vivo (Schwartz et al, 1995;O'Dell et al, 2000). Because generalized augmentation of GABAergic inhibition, whether pharmacologically or by gene targeting, may impair normal synaptic plasticity (Levkovitz et al, 1999), there may be a strong advantage for a regional rather than a general enhancement of inhibition.…”
Section: Discussionmentioning
confidence: 99%
“…Experimental models of epilepsy, for example, demonstrate a decrease in hippocampal GABA A receptor expression (Friedman et al, 1994;Rice et al, 1996) and function (Gibbs et al, 1997), suggesting that loss of inhibitory control plays a pathogenic role (Mody, 1998). Postischemic and traumatic neuronal death is reduced by the GABA potentiator diazepam (Schwartz et al, 1995;O'Dell et al, 2000). Enhancement of the GABA effect at the receptor is a reasonable strategy for increasing inhibition; this is the mechanism of many clinically useful drugs including anticonvulsants, anxiolytics, and general anesthetics (Hevers and Luddens, 1998).…”
Section: Abstract: Gaba C Receptors; Hippocampal Neurons; Adenovirusmentioning
confidence: 99%
“…Moreover, etomidate is highly selective for the GABA A receptor, exhibiting potent GABA-modulatory and GABA-mimetic effects at low micromolar concentrations (36) and, therefore, may attenuate injury by enhancing the inhibitory effects of GABA. The acute administration of diazepam, a positive modulator at the GABA A receptor, decreases mortality rate and cognitive deficits after TBI in rats (37). Furthermore, the administration of bicuculline, a GABA A antagonist, is reported to increase cognitive deficits compared with animals treated with saline (37).…”
Section: Discussionmentioning
confidence: 99%